SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013644
Filing Date
2022-08-15
Accepted
2022-08-15 17:11:39
Documents
42
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20220630x10q.htm   iXBRL 10-Q 761031
2 EX-31 bpth-20220630xex31.htm EX-31 12492
3 EX-32 bpth-20220630xex32.htm EX-32 6287
  Complete submission text file 0001558370-22-013644.txt   2583824

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20220630.xsd EX-101.SCH 25571
5 EX-101.CAL bpth-20220630_cal.xml EX-101.CAL 22041
6 EX-101.DEF bpth-20220630_def.xml EX-101.DEF 61071
7 EX-101.LAB bpth-20220630_lab.xml EX-101.LAB 182381
8 EX-101.PRE bpth-20220630_pre.xml EX-101.PRE 146055
36 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20220630x10q_htm.xml XML 241924
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 221166655
SIC: 2834 Pharmaceutical Preparations